D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 62 Citations 13,287 491 World Ranking 5682 National Ranking 171

Overview

What is she best known for?

The fields of study she is best known for:

  • Enzyme
  • Organic chemistry
  • Gene

Ana Martínez focuses on GSK-3, Biochemistry, Pharmacology, Enzyme and Enzyme inhibitor. Her GSK-3 study combines topics in areas such as Glycogen synthase, Disease, Protein kinase A and Diabetes type ii. Her Biochemistry study integrates concerns from other disciplines, such as Alzheimer's disease and Tau-protein kinase.

Her Pharmacology research is multidisciplinary, relying on both Lead compound, Phosphodiesterase, Parkinson's disease and Amyloid. Ana Martínez interconnects IC50 and In vitro in the investigation of issues within Enzyme. Her Enzyme inhibitor study incorporates themes from Acetylcholinesterase, Chemical synthesis and Stereochemistry.

Her most cited work include:

  • First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease (371 citations)
  • Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation. (284 citations)
  • GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS. (211 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Stereochemistry, GSK-3, Molecule, Pharmacology and Biochemistry. Ana Martínez combines subjects such as Endocrinology, Glycogen synthase and Internal medicine with her study of GSK-3. Her Molecule study combines topics in areas such as Crystallography, Photochemistry, Computational chemistry and Metal.

Her research integrates issues of Phosphodiesterase and Disease in her study of Pharmacology. Her Disease research is multidisciplinary, incorporating elements of Neuroscience and Bioinformatics. Her Biochemistry study focuses mostly on Enzyme and Structure–activity relationship.

She most often published in these fields:

  • Stereochemistry (12.88%)
  • GSK-3 (10.71%)
  • Molecule (9.70%)

What were the highlights of her more recent work (between 2018-2021)?

  • Kinase (6.80%)
  • Neuroscience (8.25%)
  • Amyotrophic lateral sclerosis (5.35%)

In recent papers she was focusing on the following fields of study:

The scientist’s investigation covers issues in Kinase, Neuroscience, Amyotrophic lateral sclerosis, Molecule and Drug discovery. Her Kinase research focuses on GSK-3 in particular. Her study ties her expertise on Glycogen synthase together with the subject of GSK-3.

Her Neuroscience research integrates issues from Autophagy, Mitophagy and Neurodegeneration. Her work deals with themes such as Chemical physics, Crystallography, Adsorption and Density functional theory, which intersect with Molecule. Her Structure–activity relationship study is associated with Biochemistry.

Between 2018 and 2021, her most popular works were:

  • COVID-19: Drug targets and potential treatments. (81 citations)
  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) (38 citations)
  • Good practices for reporting the photocatalytic evaluation of a visible-light active semiconductor: Bi2O3, a case study (27 citations)

In her most recent research, the most cited papers focused on:

  • Enzyme
  • Organic chemistry
  • Gene

Her scientific interests lie mostly in GSK-3, Neuroscience, Adsorption, Molecule and Amyotrophic lateral sclerosis. To a larger extent, Ana Martínez studies Biochemistry with the aim of understanding GSK-3. Her Biochemistry study combines topics from a wide range of disciplines, such as Melissa officinalis and Lamiaceae.

Her biological study spans a wide range of topics, including Chemical physics, Electron donor, Self assembled and Density functional theory. Her study in Amyotrophic lateral sclerosis is interdisciplinary in nature, drawing from both Nuclear protein, Pathological, Phosphorylation and Lymphoblast. As a member of one scientific family, Ana Martínez mostly works in the field of Structure–activity relationship, focusing on Kinase inhibition and, on occasion, Stereochemistry and IC50.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif.
Autophagy (2021)

8964 Citations

First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.

Ana Martinez;Mercedes Alonso;Ana Castro;Concepción Pérez.
Journal of Medicinal Chemistry (2002)

575 Citations

Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.

Ana Martinez;Ana Castro;Isabel Dorronsoro;Mercedes Alonso.
Medicinal Research Reviews (2002)

416 Citations

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS.

Hagit Eldar-Finkelman;Ana Martinez.
Frontiers in Molecular Neuroscience (2011)

316 Citations

Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.

Pilar Munoz-Ruiz;Laura Rubio;Esther Garcia-Palomero;Isabel Dorronsoro.
Journal of Medicinal Chemistry (2005)

237 Citations

Regulation of Inflammatory Response in Neural Cells in Vitro by Thiadiazolidinones Derivatives through Peroxisome Proliferator-activated Receptor γ Activation

Rosario Luna-Medina;Marta Cortes-Canteli;Mercedes Alonso;Angel Santos.
Journal of Biological Chemistry (2005)

231 Citations

Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors.

Ana Castro;Ana Martinez.
Current Pharmaceutical Design (2006)

229 Citations

Donepezil–tacrine hybrid related derivatives as new dual binding site inhibitors of AChE

D. Alonso;I. Dorronsoro;L. Rubio;P. Muñoz.
Bioorganic & Medicinal Chemistry (2005)

193 Citations

Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.

Ana Castro;Ana Martinez.
Mini-reviews in Medicinal Chemistry (2001)

191 Citations

Donator acceptor map for carotenoids, melatonin and vitamins.

Ana Martínez;Miguel A. Rodríguez-Gironés;Andrés Barbosa;Miguel Costas.
Journal of Physical Chemistry A (2008)

189 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ana Martínez

José Marco-Contelles

José Marco-Contelles

Spanish National Research Council

Publications: 47

Manuela Bartolini

Manuela Bartolini

University of Bologna

Publications: 38

Maria Laura Bolognesi

Maria Laura Bolognesi

University of Bologna

Publications: 37

Annia Galano

Annia Galano

Universidad Autónoma Metropolitana

Publications: 36

Vincenza Andrisano

Vincenza Andrisano

University of Bologna

Publications: 33

Richard S. Jope

Richard S. Jope

University of Miami

Publications: 27

Alireza Foroumadi

Alireza Foroumadi

Tehran University of Medical Sciences

Publications: 27

José Elguero

José Elguero

Spanish National Research Council

Publications: 26

Andrea Cavalli

Andrea Cavalli

Italian Institute of Technology

Publications: 24

Gabriel Merino

Gabriel Merino

Instituto Politécnico Nacional

Publications: 22

Laurent Meijer

Laurent Meijer

Perha Pharmaceuticals

Publications: 20

Kamil Kuca

Kamil Kuca

University of Hradec Králové

Publications: 19

Nino Russo

Nino Russo

University of Calabria

Publications: 18

Leif H. Skibsted

Leif H. Skibsted

University of Copenhagen

Publications: 18

Jesús Avila

Jesús Avila

Centro de Biología Molecular Severo Ochoa

Publications: 18

James R. Woodgett

James R. Woodgett

Lunenfeld-Tanenbaum Research Institute

Publications: 18

Trending Scientists

Giancarlo Guizzardi

Giancarlo Guizzardi

University of Twente

Jinjun Chen

Jinjun Chen

Swinburne University of Technology

Joseph A. Schumpeter

Joseph A. Schumpeter

Harvard University

Joshua T. Goodman

Joshua T. Goodman

Microsoft (United States)

Wei-Ping Zhu

Wei-Ping Zhu

Concordia University

Zhang-Jie Shi

Zhang-Jie Shi

Peking University

Guoan Luo

Guoan Luo

Tsinghua University

Christophe Biot

Christophe Biot

University of Lille

Gordon Tollin

Gordon Tollin

University of Arizona

Francisco García-Carmona

Francisco García-Carmona

University of Murcia

Yaping Li

Yaping Li

Chinese Academy of Sciences

Mats Fahlman

Mats Fahlman

Linköping University

Emma Whitelaw

Emma Whitelaw

QIMR Berghofer Medical Research Institute

Qiufeng Wang

Qiufeng Wang

Xi’an Jiaotong-Liverpool University

Jeffrey A. McNeely

Jeffrey A. McNeely

Society for Conservation Biology Asia Section

Hidenao Fukuyama

Hidenao Fukuyama

Kyoto University

Something went wrong. Please try again later.